Navigation Links
Robocycler Gradient 40 Temperature Cycler

ProductsRobocycler Gradient 40 Temperature Cycler
Company Stratagene
Item Robocycler Gradient 40 Temperature Cycler
Features Inquire
Description With RoboCycler Gradient 40 or 96 temperature cyclers, the gradient block can be set to generate a linear temperature range of up to 14 or 22 across the 40- or 96-well block, respectively with a temperature difference of up to 2C between adjacent wells in each row. This means you can test up to 12 different annealing temperatures in a single experiment. Once the optimal temperature has been determined, simply set the gradient block to a single temperature of up to 99C for PCR cycling.
Info Stratagene
Customer Service: (800) 424-5444
Web site: http://www.stratagene.com

Related medicine products :

1. Robocycler 40 Temperature Cycler
2. Robocycler Gradient 96 Temperature Cycler
3. Robocycler 96 Temperature Cycler
4. Milli-Q Gradient A10 System
5. Milli-Q Gradient A10 bench-integrated system
6. Milli-Q Gradient System (non-TOC)
7. Milli-Q Gradient bench-integrated system (non-TOC)
8. RoboCycler Gradient 40 Temperature Cycler
9. RoboCycler 96 Gradient Temperature Cycler
10. RoboCycler 96 Gradient Cycler
11. MyGenie 96 Gradient Thermal Block
... Howland lock handle - Chrome-plated brass. Rusch ... standard laryngoscope handles that are compatible with ... standards. The designs of these handles have ... use the world over to minimize maintenance ...
... brass. Available Small/Penlight, Med/Standard, Stubby/Short, Pediatric/Short. ... high quality standard laryngoscope handles that ... manufactured to ISO 7673 standards. The ... continually refined through many years of ...
... are designed with the clinician in mind. ... be removed to simplify cleaning - no ... unique snap-on mechanism eliminates screws that can ... interchangeable with other green coded fiber optic ...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Medicine Products:
(Date:2/8/2016)... ... ... A man who has struggled to quit smoking, a man who has struggled with hair ... solutions to his problems – and he did. Now Nabat, a serial entrepreneur featured as ... breakthrough inventions to the world and better people's lives. His own experience with nicotine addiction ...
(Date:2/8/2016)... ... 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving the ... has teamed up with Citizens Opposed to Domestic Abuse in support of its efforts ... all those victimized by the fear of violence in their own homes, donations may ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s longest running and ... companies. Attendees also get to see the most incredible gardens and home improvement ... , at the Colorado Convention Center - 700 14th St. Denver CO, is an ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Company, Inc. (NYSE MKT: AXN) today announced that for the ... the Company achieved revenue of $8,195,839, a 27% improvement on ... 2015. --> --> The ... $2,068,635, or $.03 per share, up 265% from the net ... of fiscal year 2015. Gross margin for the three months ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  Sangamo ... in therapeutic genome editing, announced that the U.S. ... Company,s Investigational New Drug (IND) application for SB-318, ... life-long therapy for Mucopolysaccharidosis Type I (MPS I). ... enables Sangamo to initiate a Phase 1/2 clinical ...
Breaking Medicine Technology: